arabinofuranosyluracil has been researched along with Muscular Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JM | 1 |
| Tak, WY | 1 |
| Fung, J; Lai, CL; Seto, WK; Yuen, MF | 1 |
| Choe, WH; Kim, BK; Ko, SY; Kwon, SY; Lee, CH; Lim, SD; Oh, J; Rhee, KH; Seo, TH | 1 |
| Fleischer, RD; Lok, AS | 1 |
| Hwang, JH; Jang, JH; Jeong, SH; Kim, HS; Kim, JW; Kim, N; Lee, DH; Lee, SH; Myung, HJ; Park, YS | 1 |
| Cho, YK; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JH; Sohn, CI | 1 |
| Cho, CM; Jeon, SW; Jung, MK; Kweon, YO; Park, JY; Park, SY; Sohn, YK; Tak, WY | 1 |
| Shouval, D | 1 |
| Choi, YY; Hwang, HS; Jang, SJ; Kim, YH; Lee, JA; Lee, MH; Paik, SS; Yoo, DH | 1 |
| Choi, DJ; Jung, YK; Kim, JH; Kim, YS; Kwon, OS; Lee, JJ; Lee, JW; Lee, YJ | 1 |
2 review(s) available for arabinofuranosyluracil and Muscular Diseases
| Article | Year |
|---|---|
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
Topics: Acidosis, Lactic; Adenine; Administration, Oral; Antiviral Agents; Arabinofuranosyluracil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Organophosphonates; Pharmacovigilance; Pregnancy; Telbivudine; Tenofovir; Thymidine | 2014 |
Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; Drug Discovery; Early Termination of Clinical Trials; Hepatitis B, Chronic; Humans; Lamivudine; Mitochondrial Myopathies; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Pyrimidinones; Republic of Korea; Telbivudine; Thymidine | 2009 |
9 other study(ies) available for arabinofuranosyluracil and Muscular Diseases
| Article | Year |
|---|---|
Myopathy, Drugs, and Mitochondria.
Topics: Arabinofuranosyluracil; Humans; Mitochondria; Mitochondrial Myopathies; Muscular Diseases | 2017 |
[Antiviral effect of entecavir switching therapy in chronic hepatitis B patients with clevudine-associated myopathy].
Topics: Antiviral Agents; Arabinofuranosyluracil; Female; Guanine; Hepatitis B, Chronic; Humans; Male; Muscular Diseases | 2013 |
Clevudine myopathy in patients with chronic hepatitis B.
Topics: Adult; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; DNA, Viral; Electromyography; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Middle Aged; Muscular Diseases | 2009 |
Clevudine for chronic hepatitis B: antiviral response, predictors of response, and development of myopathy.
Topics: Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Muscular Diseases; Prognosis; Republic of Korea; Retrospective Studies; Treatment Outcome; Viral Load | 2011 |
Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Biomarkers; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Muscular Diseases; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load; Virus Replication | 2010 |
Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Arabinofuranosyluracil; Biopsy; Creatine Kinase; Dose-Response Relationship, Drug; Exercise Tolerance; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; L-Lactate Dehydrogenase; Lactates; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Prospective Studies; Retrospective Studies; Young Adult | 2010 |
Focus.
Topics: Albumins; Antiviral Agents; Arabinofuranosyluracil; Cholangitis, Sclerosing; Cholestasis; Dialysis Solutions; Gastrointestinal Neoplasms; Hepatitis B; Humans; Incidence; Muscular Diseases; Pruritus; Renal Dialysis; Risk Factors | 2010 |
18F-FDG PET/CT of drug-induced myopathy in a patient with chronic hepatitis B on long-term clevudine therapy.
Topics: Adult; Arabinofuranosyluracil; Fluorodeoxyglucose F18; Hepatitis B, Chronic; Humans; Male; Muscular Diseases; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed | 2011 |
[Efficacy of entecavir switching therapy in chronic hepatitis B patients with clevudine-induced myopathy].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Muscular Diseases | 2013 |